The Mumbai-based firm said it plans to launch Molnupiravir under the brand name Cipmolnu.
Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government.
According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decision to suspend the exceptional and temporary authorisation for import and distribution of Covaxin after Bharat Biotech informed the South America government about the termination of its pact with its Brazilian partners.
Bharat Biotech’s COVID-19 vaccines were "not considered" for emergency use authorisation on December 9 over lack of data. But what is emergency use authorisation and how is it different from full approval? What is the process of getting a EUA in India and is it safe to use? What are the risks involved? Here are four key questions answered about the new COVID-19 buzz word - EUA